Home Newsfeeds Cyteir Therapeutics Q2 EPS $(0.34) Up From $(4.83) YoY

Cyteir Therapeutics Q2 EPS $(0.34) Up From $(4.83) YoY

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.34) per share. This is a 92.96 percent increase over losses of $(4.83) per share from the same period last year.

byBenzinga Newsdesk

August 8, 2022

1 minute read

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.34) per share. This is a 92.96 percent increase over losses of $(4.83) per share from the same period last year.

Goldman Sachs Maintains Sell on Allison Transmission, Lowers Price Target to $32

By Benzinga Newsdesk

October 14, 8:28 AM

Goldman Sachs analyst Jerry Revich maintains Allison Transmission (NYSE:ALSN) with a Sell and lowers the price target from $37 to $32.

ALSN

Schwab Reports Monthly Activity Highlights; Core Net New Assets Brought To The Company By New And Existing Clients Totaled $21.7B; Total Client Assets Were $8.18T As Of Month-End November, Up 12% YoY

By Benzinga Newsdesk

December 14, 9:47 AM

The Charles Schwab Corporation released its Monthly Activity Report today. Company highlights for the month of November 2023 include:This press release features multimedia. View the full release here:

SCHW